Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-10-02

Clinical Trial Update: Role of Octreotide in Non Variceal Bleeding [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial exploring octreotide for non-variceal gastrointestinal bleeding; results not yet disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OCTREOTIDE (OCTREOTIDE ACETATE)

Snippet

Sponsor: National Hepatology & Tropical Medicine Research Institute | Conditions: Non-variceal Gastrointestinal Bleeding | Phase 2, Phase 3 | Status: UNKNOWN